A. Rui Gomes, Clara Simães, Olga Dias, Catarina Almeida and Sónia Gonçalves
to DFM (e.g., bodybuilding).
This study was conducted at Psychology Research Centre (UID/PSI/01662/2013), University of Minho, and supported by the Portuguese Foundation for Science and Technology, the Portuguese Ministry of Science, Technology and Higher Education through national funds and co-financed by FEDER through COMPETE2020 under the PT2020 Partnership Agreement (POCI-01-0145-FEDER-007653).
Ahmad MM. Psychometric evaluation of the Cognitive Appraisal of Health Scale with patients with prostatecancer. J Adv
Paweł Cięszczyk, Aleksandra Zarębska, Zbigniew Jastrzębski, Michał Sawczyn, Izabela Kozakiewicz-Drobnik, Agata Leońska-Duniec, Mariusz Kaczmarczyk, Agnieszka Maciejewska-Skrendo, Piotr Żmijewski, Grzegorz Trybek, Wojciech Smółka, Jan Pilch, Katarzyna Leźnicka, Ewelina Lulińska-Kuklik, Marek Sawczuk and Myosotis Massidda
methylenetetrahydrofolate reductase gene: an additional risk factor for neural-tube defects? Am J Hum Genet , 1998; 62: 1044–1051 10.1086/301825
van der Put NM Gabreels F Stevens EM Smeitink JA Trijbels FJ Eskes TK van den Heuvel LP Blom HJ A second common mutation in the methylenetetrahydrofolate reductase gene: an additional risk factor for neural-tube defects? Am J Hum Genet 1998 62 1044 1051
Weinstein SJ, Stolzenberg-Solomon R, Pietinen P, Taylor PR, Virtamo J, Albanes D. Dietary factors of onecarbon metabolism and prostatecancer risk. Am J Clin Nutr, 2006; 84: 929–935 10
Dariusz Jastrzębski, Aleksandra Żebrowska, Sebastian Rutkowski, Anna Rutkowska, Joanna Warzecha, Bettina Ziaja, Aleksandra Pałka, Barbara Czyżewska, Damian Czyżewski and Dariusz Ziora
According to the incidence of disease, lung cancer is the second-most frequent cancer after breast cancer in women and the second-most frequent cancer after prostatecancer in men ( Ferlay et al., 2015 ). Early diagnosis and new therapies together with the strong dynamics of newly occurring cases pertain to the growth of patients suffering from lung cancer. In Poland, there are over 22,000 registered patients with lung cancer (lung cancer in Poland – medical perspective). The majority of cases occur after the age of 50, and approximately 50% of